Clinical Trials Logo

Submental Fat clinical trials

View clinical trials related to Submental Fat.

Filter by:
  • None
  • Page 1

NCT ID: NCT04867434 Recruiting - Submental Fat Clinical Trials

Efficacy and Safety of RZL-012 on Submental Fat Reduction

Start date: June 15, 2021
Phase: Phase 2
Study type: Interventional

A total of 135 eligible male or female subjects will be randomized according to a predetermined randomization scheme (1:1:1 ratio) to receive a single multi-injection treatment of high dose RZL-012, low dose RZL-012, or placebo on Day 0. They will be monitored for safety and efficacy over 84 days.

NCT ID: NCT04258761 Active, not recruiting - Submental Fat Clinical Trials

A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")

Start date: October 10, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to find out more about an investigational drug, 10XB-101, for people with fat under their chin which they would like to remove. The Sponsor of this study thinks there may be a chance this drug could be used to dissolve, or "melt" this fat away.

NCT ID: NCT04144049 Completed - Submental Fat Clinical Trials

A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat

Start date: September 10, 2019
Phase: Phase 2
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled, dose-ranging, parallel, multi-center, phase II study to evaluate the efficacy and safety of MT921 in subjects with moderate to severe submental fat.

NCT ID: NCT04086823 Completed - Submental Fat Clinical Trials

A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.

Start date: February 25, 2020
Phase: Phase 2
Study type: Interventional

Twenty-Eight (28) subjects (12 for cohort 1 and 16 for cohort 2 ) will be included in the study. Subjects in each cohort will be injected with a different dose of RZL-012. The total of 28 subjects will be enrolled in 2 clinical sites.

NCT ID: NCT03946592 Recruiting - Submental Fat Clinical Trials

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

SMF
Start date: May 7, 2019
Phase: Phase 3
Study type: Interventional

Evaluate the efficacy and safety of DWJ211 in patient with moderate or severe submental fat

NCT ID: NCT03005717 Completed - Submental Fat Clinical Trials

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Start date: December 22, 2016
Phase: Phase 2
Study type: Interventional

Study LIPO-202-CL-31 is a multi center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of LIPO-202 versus placebo on submental bulging due to subcutaneous fat. Approximately 150 participants of either gender who have a "Moderate Bulge" or "Large Bulge" in the submental fat (on Patient-Reported Submental Bulging Scale [PR-SBS] and Clinician-Reported Submental Bulging Scale [CR-SBS]) will be recruited for this study.

NCT ID: NCT02163902 Completed - Healthy Clinical Trials

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Start date: December 2013
Phase: Phase 3
Study type: Interventional

The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.

NCT ID: NCT02159729 Completed - Healthy Clinical Trials

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Start date: February 2009
Phase: Phase 2
Study type: Interventional

This was a long-term follow-up study of participants who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)